Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Oxford Immunotec (OXFD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 384,436
  • Shares Outstanding, K 26,623
  • Annual Sales, $ 59,750 K
  • Annual Income, $ 120,780 K
  • 60-Month Beta 0.42
  • Price/Sales 6.46
  • Price/Cash Flow 21.68
  • Price/Book 1.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.05
  • Number of Estimates 3
  • High Estimate -0.02
  • Low Estimate -0.09
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +80.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.07 +4.41%
on 06/14/19
15.42 -4.73%
on 06/05/19
-0.56 (-3.67%)
since 05/17/19
3-Month
14.07 +4.41%
on 06/14/19
18.25 -19.48%
on 03/20/19
-3.32 (-18.43%)
since 03/19/19
52-Week
11.66 +25.99%
on 07/30/18
19.19 -23.45%
on 09/25/18
+0.20 (+1.38%)
since 06/19/18

Most Recent Stories

More News
Here's Why You Should Hold on to Stryker (SYK) Stock Now

Stryker (SYK) is gaining steadily from strong international growth and robust product portfolio. However, unfavorable pricing environment remains a woe.

OXFD : 14.69 (+1.73%)
SYK : 200.49 (+1.17%)
HAE : 117.08 (+2.67%)
CSII : 43.45 (-0.48%)
Here's Why You Should Hold on to Stryker (SYK) Stock Now

Stryker (SYK) is gaining steadily from strong international growth and robust product portfolio. However, unfavorable pricing environment remains a woe.

OXFD : 14.69 (+1.73%)
SYK : 200.49 (+1.17%)
HAE : 117.08 (+2.67%)
CSII : 43.45 (-0.48%)
Here's Why You Should Hold on to Stryker (SYK) Stock Now

Stryker (SYK) is gaining steadily from strong international growth and robust product portfolio. However, unfavorable pricing environment remains a woe.

OXFD : 14.69 (+1.73%)
SYK : 200.49 (+1.17%)
HAE : 117.08 (+2.67%)
CSII : 43.45 (-0.48%)
Here's Why You Should Hold on to Stryker (SYK) Stock Now

Stryker (SYK) is gaining steadily from strong international growth and robust product portfolio. However, unfavorable pricing environment remains a woe.

OXFD : 14.69 (+1.73%)
SYK : 200.49 (+1.17%)
HAE : 117.08 (+2.67%)
CSII : 43.45 (-0.48%)
Here's Why You Should Hold on to Stryker (SYK) Stock Now

Stryker (SYK) is gaining steadily from strong international growth and robust product portfolio. However, unfavorable pricing environment remains a woe.

OXFD : 14.69 (+1.73%)
SYK : 200.49 (+1.17%)
HAE : 117.08 (+2.67%)
CSII : 43.45 (-0.48%)
Here's Why You Should Hold on to Stryker (SYK) Stock Now

Stryker (SYK) is gaining steadily from strong international growth and robust product portfolio. However, unfavorable pricing environment remains a woe.

OXFD : 14.69 (+1.73%)
SYK : 200.49 (+1.17%)
HAE : 117.08 (+2.67%)
CSII : 43.45 (-0.48%)
Here's Why You Should Hold on to Stryker (SYK) Stock Now

Stryker (SYK) is gaining steadily from strong international growth and robust product portfolio. However, unfavorable pricing environment remains a woe.

OXFD : 14.69 (+1.73%)
SYK : 200.49 (+1.17%)
HAE : 117.08 (+2.67%)
CSII : 43.45 (-0.48%)
Here's Why You Should Hold on to Stryker (SYK) Stock Now

Stryker (SYK) is gaining steadily from strong international growth and robust product portfolio. However, unfavorable pricing environment remains a woe.

OXFD : 14.69 (+1.73%)
SYK : 200.49 (+1.17%)
HAE : 117.08 (+2.67%)
CSII : 43.45 (-0.48%)
Here's Why You Should Hold on to Stryker (SYK) Stock Now

Stryker (SYK) is gaining steadily from strong international growth and robust product portfolio. However, unfavorable pricing environment remains a woe.

OXFD : 14.69 (+1.73%)
SYK : 200.49 (+1.17%)
HAE : 117.08 (+2.67%)
CSII : 43.45 (-0.48%)
Here's Why You Should Hold on to Stryker (SYK) Stock Now

Stryker (SYK) is gaining steadily from strong international growth and robust product portfolio. However, unfavorable pricing environment remains a woe.

OXFD : 14.69 (+1.73%)
SYK : 200.49 (+1.17%)
HAE : 117.08 (+2.67%)
CSII : 43.45 (-0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade OXFD with:

Business Summary

Oxford Immunotec Global PLC is a medical diagnostics company. It develops new tests for various diseases based on its, patented T cell measurement technology. The company's first product is the T-SPOT(R). Oxford Immunotec Global PLC is headquartered in Abingdon, the United Kingdom.

See More

Key Turning Points

2nd Resistance Point 15.02
1st Resistance Point 14.85
Last Price 14.69
1st Support Level 14.39
2nd Support Level 14.10

See More

52-Week High 19.19
Fibonacci 61.8% 16.31
Fibonacci 50% 15.43
Last Price 14.69
Fibonacci 38.2% 14.54
52-Week Low 11.66

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar